JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
PLX Financials - Protalix Biotherapeutics Income & Cash Flow | Ledgeburg
PLX - Protalix Biotherapeutics, Inc.
USD | NYSE | Healthcare
Summary
Summary PLX Stock
Financials
Financials PLX Stock
Loading...
Loading...
Income Statement
Income Statement PLX Stock
Balance Sheet
Balance Sheet PLX Stock
Cash Flow Statement
Cash Flow Statement PLX Stock
Loading...
Loading...
Home
Stocks
Protalix Biotherapeutics, Inc. (PLX)
Financials
Financials of PLX
Loading...
Loading...
Loading...
Loading...
Revenue
$52.744M
Operating Income
$-5.5M
Net Income
$-6.604M
Share Count (Basic)
78.546234M
Operating Cash Flow
$-11.993M
Free Cash Flow
$-13.631M
Cash And Short-Term Equivalents
$14.68M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-30M
-20M
-10M
0
10M
Annual
Quarterly
Margins
Gross
Operating
Net
-50%
0%
50%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-5M
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26